knowledge | a-connect

AGILE – The art of adapting to change and innovation

Increasing complexity and the pace of change requires a new mindset and approach to leadership

Patients not patents – new times spell new solutions for the pharma industry

As pharma redefines itself in the digital age, companies all over the world are setting their sights on new target groups

Blockchain-ing the Money Machine

How the technology that powers bitcoin can reshape the financial services landscape

Who’s afraid of the robo-consultant?

Around 66% of Americans believe that artificial intelligence (AI) will soon replace most of the work that is currently completed by humans.

From PowerPoint to bottom line

Supercharging your implementation efforts to deliver on the promise of your strategy

filter by

“Brexit means Brexit”—but what will it mean for pharmaceutical market access?

Part 1: Why does it matter? - a guest article from Neil Grubert

16 August 2016

Transitioning to Personalised Healthcare: Understanding the key scientific and practical challenges

Read about the R&D challenges Life Science organisations face in an guest article from Munna Choudhury

2 June 2016

Pricing and Market Access – People Skills

An article from the European Pharmaceutical Contractor on the shifts in pharma and their implications for Pricing & Market Access teams

18 May 2016

Personalised healthcare – a new age in drug development

Read about the 4 key trends shaping the PHC approach and its implications for Life Science companies

17 March 2016

a-connect addresses Pharma Stakeholders at the World Pharma Pricing & Market Access Congress 2016

Read about the key learnings from the P&MA conference

4 March 2016

Life Science Projects in 2015

An overview of a-connect projects successfully delivered in Life Science

18 January 2016

a-connect tags

All

join the discussion on join the discussion on

< 1 2

Industry

Business Functions